Although little is known regarding specific heterocellular interactions in CRC, several studies have revealed that colonic epithelial cells can activate fibroblasts via TGF-β 25, 31 and poor-prognosis mesenchymal CRC subtypes display TGF-β-induced epithelial expression signatures. This evidence concerns the gene TGFB1 and colorectal carcinoma.